Brian M Stuglik insider trades
Open-market stock purchases and sales by Brian M Stuglik, Director at Puma Biotechnology, Inc, from SEC Form 4 filings since Sep 6, 2017.
Track record: 0% of 3 scored buys are up 5% or more since purchase, averaging -50%.